Sacubitril And Valsartan Tablet
Product Images NDC 70771-1921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 70771-1921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

24 mg / 26 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 01)

24 mg / 26 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 01)
This text appears to be a product label for a medication called Sacubitril and Valsartan. The label provides instructions on storage conditions (20°C to 25°C, protect from moisture), mentions the child-resistant packaging, and indicates the manufacturer as "Zydus Lifesciences Ltd." The medication comes in the form of tablets with a dosage of 24mg/26mg.*
FDA Label Image

49 mg/51 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 02)

49 mg/51 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 02)
This is a coding template for a medication named "Sacubitril" with a dosage of 24 mg/51 mg. The package is child-resistant and should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between controlled room temperature. It is important to protect the tablets from moisture. The medication is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India. This product is only available with a prescription and contains 60 tablets.*
FDA Label Image

97 mg/103 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.